EU Clinical Trial Information System (CTIS)

Brand Logo

Brand Logo Light

Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.

I searched for some studies on AstraZeneca Clinical Trials, and found these studies that may also be of interest to you.
Here is the link to my search results

Official Title

The purpose of the investigation is to confirm the safety of patients receiving Symbicort Turbuhaler as maintenance and reliever therapy ( Symbicort SMART) under the post-marketing actual use.

Clinical Experience Investigation of Symbicort Turbuhaler as maintenance therapy and reliever therapy

Symbicort Turbuhaler 30/60
                Clinical Experience Investigation for treatment with Symbicort as maintenance therapy and as needed in response to symptoms

NCT ID

Therapeutic Area

Research Site

Symbicort Turbuhaler 30/60
            Clinical Experience Investigation for treatment with Symbicort as maintenance therapy and as needed in response to symptoms

Clinical Experience Investigation of Symbicort Turbuhaler as maintenance therapy and reliever therapy

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Documents available

CSR Synopsis

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator